| 1 |
Adenosine A2A Receptor Activation Enhances Blood–Tumor Barrier Permeability in a Rodent Glioma Model |
|
|
| Amélie Vézina, Monica Manglani, DreeAnna Morris, Brandon Foster, Matthew McCord, Hua Song, Meili Zhang, Dionne Davis, Wei Zhang, Jessica Bills, Kunio Nagashima, Priya Shankarappa, Jessica Kindrick, Stuart Walbridge, Cody J. Peer, William D. Figg, Mark R. Gilbert, Dorian B. McGavern, Leslie L. Muldoon, Sadhana Jackson |
|
| Molecular Cancer Research. 2021; 19(12): 2081 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Regadenoson Stress Testing: A Comprehensive Review With a Focused Update |
|
|
| Karim O Elkholy, Omar Hegazy, Adeniyi Okunade, Suat Aktas , Temitope Ajibawo |
|
| Cureus. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Pharmacology, Part 4: Nuclear Cardiology |
|
|
| Geoffrey M. Currie |
|
| Journal of Nuclear Medicine Technology. 2019; 47(2): 97 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors |
|
|
| David S. Hong, Patricia LoRusso, Omid Hamid, Filip Janku, Muaiad Kittaneh, Daniel V.T. Catenacci, Emily Chan, Tanios Bekaii-Saab, Shirish M. Gadgeel, Robert D. Loberg, Benny M. Amore, Yuying C. Hwang, Rui Tang, Gataree Ngarmchamnanrith, Eunice L. Kwak |
|
| Clinical Cancer Research. 2019; 25(8): 2403 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Pharmacological Activity and Clinical Use of PDRN |
|
|
| Francesco Squadrito, Alessandra Bitto, Natasha Irrera, Gabriele Pizzino, Giovanni Pallio, Letteria Minutoli, Domenica Altavilla |
|
| Frontiers in Pharmacology. 2017; 8 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
When to re-dose regadenoson? |
|
|
| Gregory S. Thomas,Aaron F. Jolly,Michael Safani |
|
| Journal of Nuclear Cardiology. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthma |
|
|
| Carlos Salgado Garcia,Amelia Jimenez Heffernan,Elena Sanchez de Mora,Carlos Ramos Font,Juana Lopez Martin,Francisco Rivera de los Santos,Ignacio Ynfante Milá |
|
| European Journal of Nuclear Medicine and Molecular Imaging. 2014; 41(1): 119 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthma |
|
|
| Garcia, C.S., Heffernan, A.J., Sanchez De Mora, E., Rivera De Los Santos, F., Ynfante Milá, I. |
|
| European Journal of Nuclear Medicine and Molecular Imaging. 2014; 41(1): 119-125 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole |
|
|
| Friedman, M. and Spalding, J. and Kothari, S. and Wu, Y. and Gatt, E. and Boulanger, L. |
|
| Journal of Medical Economics. 2013; 16(4): 449-460 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole |
|
|
| Michelle Friedman,James Spalding,Smita Kothari,You Wu,Elyse Gatt,Luke Boulanger |
|
| Journal of Medical Economics. 2013; 16(4): 449 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
